Semaglutide improves health-related quality of life vs placebo when added to standard-of care in patients with type 2 diabetes at high risk (SUSTAIN 6)

Thumbnail Image
Identifiers
URI: http://hdl.handle.net/11268/10013

Publication date

2018

Authors

Polonsky, William
Réa, Rosangela
Warren, Mark
Vilsbøll, Tina

Advisors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics

Google Scholar

Research Projects

Organizational Units

Journal Issue

Abstract

Description

UNESCO Subjects

Medicina preventiva
Enfermedad cardiovascular

Keywords

Bibliographic reference

Jodar, E., Polonsky, W., Rea, R., Warren, M., Vilsboll, T., Hakan-Bloch, J., Vrazic, H., Lindberg, S., & Bain, S. C. (2018). Semaglutide improves health-related quality of life vs placebo when added to standard-of care in patients with type 2 diabetes at high risk (SUSTAIN 6). Diabetologia, 61(S1), S372-S373.

Type of document

conference output

Collections

Otras Áreas de Investigación de Salud